Related Experiment Video
Updated: Mar 19, 2026

14:10
Protocol for Plasmodium falciparum Infections in Mosquitoes and Infection Phenotype Determination
Published on: July 4, 2007
18.5K
Artemisinin-Resistant Plasmodium falciparum Malaria
Rick M Fairhurst1, Arjen M Dondorp2,3
1Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852.
Microbiology Spectrum
|June 24, 2016
Summary
Drug-resistant malaria is emerging in Southeast Asia, threatening global elimination efforts. Studies identify K13 gene mutations causing artemisinin resistance, leading to treatment failures and urgent calls for new antimalarial strategies.
Area of Science:
- Malariology
- Genetics
- Pharmacology
Background:
- Southeast Asia is a hotspot for Plasmodium falciparum malaria drug resistance.
- Emergence of resistance to artemisinins, the primary antimalarial drugs, is a critical global health concern.
- This resistance threatens the efficacy of artemisinin combination therapies (ACTs), the current first-line treatment.
Purpose of the Study:
- To define the phenotypes, genetic determinants, molecular mechanisms, and clinical impact of artemisinin resistance in Southeast Asia.
- To assess the implications of artemisinin resistance for malaria treatment and elimination strategies.
- To inform urgent clinical and preclinical research needed to combat widespread drug resistance.
Main Methods:
- Clinical studies in patients with malaria.
- In vitro parasite survival assays.
- Genomic and transcriptomic analyses to identify resistance markers and pathways.
- Assessment of K13 gene mutations and their association with resistance phenotypes.
Main Results:
- Artemisinin resistance is characterized by slow parasite clearance and increased survival of early-stage parasites.
- Single nucleotide polymorphisms (SNPs) in the Plasmodium falciparum K13 gene are the primary cause of artemisinin resistance.
- Resistance is linked to an upregulated unfolded protein response pathway and selects for partner drug resistance, accelerating ACT failures.
Conclusions:
- Artemisinin resistance in Southeast Asia poses a significant threat to malaria treatment and global control efforts.
- Urgent clinical studies are needed to monitor ACT efficacy, test new drug combinations, and develop novel antimalarials.
- Preventing the spread of artemisinin and partner drug resistance from Southeast Asia to Africa is paramount.
More Related Videos
Related Concept Videos
Diversity of Protists II
2.0K
Alveolates are a group of organisms recognized by the presence of alveoli, which are cytoplasmic sacs located beneath the cell membrane. While their function remains uncertain, alveoli may help regulate water balance by controlling how much water enters and leaves the cell. In dinoflagellates, these structures may serve as armor plates. There are three major types of alveolates: ciliates, which move using cilia; dinoflagellates, which use flagella for movement; and apicomplexans, which are...
2.0K
Anthelminthic Agents
11
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
11
Symbiosis
38.2K
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
38.2K

